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We report the isolation and amino acid sequences of six novel
dimeric disintegrins from the venoms of Vipera lebetina obtusa
(VLO), V. berus (VB), V. ammodytes (VA), Echis ocellatus (EO)
and Echis multisquamatus (EMS). Disintegrins VLO4, VB7, VA6
and EO4 displayed the RGD motif and inhibited the adhesion
of K562 cells, expressing the integrin α5β1 to immobilized
fibronectin. A second group of dimeric disintegrins (VLO5 and
EO5) had MLD and VGD motifs in their subunits and blocked the
adhesion of the α4β1 integrin to vascular cell adhesion molecule
1 with high selectivity. On the other hand, disintegrin EMS11
inhibited both α5β1 and α4β1 integrins with almost the same
degree of specificity. Comparison of the amino acid sequences
of the dimeric disintegrins with those of other disintegrins
by multiple-sequence alignment and phylogenetic analysis, in
conjunction with current biochemical and genetic data, supports
the view that the different disintegrin subfamilies evolved from
a common ADAM (a disintegrin and metalloproteinase-like)
scaffold and that structural diversification occurred through
disulphide bond engineering.
Key words: disintegrin, disulphide bond, evolution, protein
sequence, snake venom protein.
INTRODUCTION
Crotalid and viperid venoms contain a large number of haemor-
rhagic proteins. Haemorrhage is the result of the synergistic
action of certain metalloproteinases which degrade the extra-
cellular matrix surrounding blood vessels and proteins that
interfere with haemostasis (reviewed in [1]). Snake venom
haemorrhagic metalloproteinases have been classified according
to their domain structure into three classes [2]. PI metalloprotein-
ases (20–30 kDa) are single-domain proteins with relatively weak
haemorrhagic activity. The PII class metalloproteinases (30–
60 kDa) contain a disintegrin domain at the C-terminus of a metal-
loproteinase domain structurally similar to that in the PI class.
Haemorrhagins of the PIII class are large toxins (60–100 kDa)
with the most potent activity, and comprise multidomain
enzymes built up of an N-terminal metalloproteinase domain
and C-terminal disintegrin-like and cysteine-rich domains [1–3].
Disintegrins are released in the venoms by proteolytic processing
of PII metalloproteinases [2,3], and inhibit integrin–ligand
interactions. However, the involvement of the disintegrin-like
domains of PIII haemorrhagins in integrin recognition remains
controversial [4].
Disintegrins are divided into five different groups according to
their polypeptide length and number of disulphide bonds [4–7].
The first group includes short-sized disintegrins, including
echistatin, eristocophin, eristostatin and ocellatusin, which are
composed of 49–51 residues and four disulphide bonds [8–10].
The second group is formed by medium-sized disintegrins, which
contain approx. 70 amino acids and six disulphide bonds [8,11–
13]; most of the 50 or more different disintegrins characterized
to date, including trigramin, kistrin, flavoridin, albolabrin and
Abbreviations used: ADAM, a disintegrin and metalloproteinase-like; CHO, Chinese-hamster ovary; EMS, disintegrin from the venom of Echis
multisquamatus; EO, VA, VB, VLO, disintegrins from the venoms of Echis ocellatus, Vipera ammodytes, V. berus and V. lebetina obtusa respectively;
HBSS, Hanks balanced salt solution; MALDI–TOF-MS; matrix-assisted laser-desorption ionization–time-of-flight mass spectrometry; PE, pyridylethylated;
TFA, trifluoroacetic acid; VCAM, vascular cell adhesion molecule.
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barbourin, belong to this group. The third group includes the
long-sized disintegrin bitistatin, an 84-residue polypeptide cross-
linked by seven disulphide bonds [14] and salmosin 3 [15]. The
disintegrin domains of PIII snake-venom metalloproteinases
containing approx. 100 amino acids with 16 cysteine residues
involved in the formation of eight disulphide bonds [1–4,16]
constitute the fourth group of the disintegrin family. Unlike
short-, medium- and long-sized disintegrins, which are single-
chain molecules [4], the fifth group is composed of homo-
and heterodimers. Dimeric disintegrins like contortrostatin,
EC3 and EMF-10 [5–7] contain subunits of approx. 67 residues
with ten cysteine residues involved in the formation of four
intrachain disulphide bonds and two interchain cystine linkages
[17]. Bilitoxin-1 represents another homodimeric disintegrin
comprising disulphide-bonded polypeptides each containing 15
cysteine residues [18].
The integrin-inhibitory activity of disintegrins depends on the
appropriate pairing of cysteine residues, which determine
the conformation of the inhibitory loop. In most single-chain
disintegrins, the active sequence is the tripeptide RGD [4], the
exceptions being barbourin and ussuristatin 2, two medium-sized
disintegrins possessing an active KGD sequence [19,20] and
atrolysin E, which has an MVD motif in its inhibitory loop
[3]. NMR studies of several short- (echistatin) and medium-
sized (kistrin, flavoridin, albolabrin) disintegrins revealed that
the active tripeptide is located at the apex of a mobile loop
protruding 14–17 Å (1 Å = 0.1 nm) from the protein core [11,21–
23]. RGD-containing disintegrins show different levels of binding
affinity and selectivity towards integrins which recognize the RGD
sequence in their ligands (i.e. αIIbβ3, αvβ3 and α5β1 [24]).
KGD-containing barbourin inhibits the αIIbβ3 integrin with a
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high degree of selectivity [19]. The integrin specificity profile of
atrolysin E is unknown, although due to its inhibition of ADP-
and collagen-stimulated platelet aggregation, αIIbβ3 may be one
of its target receptor(s) [25].
Dimeric disintegrins exhibit the highest level of sequence
diversity in their integrin-binding motifs. EC3, a heterodimeric
disintegrin from Echis carinatus (= E.c. sochureki or E.
sochureki) venom, is a selective and potent antagonist of the
binding of α4β1 and α4β7 integrins to immobilized vascular
cell adhesion molecule (VCAM)-1 and mucosal addressin cell
adhesion molecule (MAdCAM)-1 respectively. It is also a weaker
inhibitor of α5β1 and αIIbβ3 integrins and does not inhibit αvβ3
integrin [6]. The inhibitory activity of EC3 towards α4 integrins
is associated with the MLD sequence of its B subunit. The A
subunit of EC3 contains a VGD motif, and the ability of EC3
to inhibit α5β1 resides in both subunits [6]. EMF-10, another
heterodimeric disintegrin isolated from the venom of Eristocophis
macmahoni, is an extremely potent and selective inhibitor of
integrin α5β1, binding to fibronectin and partially inhibiting the
adhesion of cells expressing integrins αIIbβ3, αvβ3 and α4β1
to their appropriate ligands [7]. Selective recognition of α5β1
by EMF-10 is associated with the MGD(W) sequence, a motif
located in the active loop of the B subunit, and expression of α5β1-
inhibitory activity may also depend on the RGD(N) motif in the A
subunit [7]. The presence of a WGD motif in CC8, a heterodimeric
disintegrin isolated from the venom of the North African sand
viper, Cerastes cerastes cerastes, has been reported to increase
its inhibitory effect on αIIbβ3, αvβ3 and α5β1 integrins [26].
Dimeric disintegrins are thus valuable tools for identifying novel
integrin-binding sequence motifs, which may shed light on the
structural requirements of selective integrin inhibition.
We have determined the amino acid sequences of seven novel
dimeric disintegrin subunits isolated from the venoms of Vipera
lebetina obtusa, V. berus, V. ammodytes, E. ocellatus and E.
multisquamatus. Their integrin-inhibition selectivity was investi-
gated using a panel of cell lines expressing defined integrin
receptors. The apparent common ancestry of mammalian metal-
loproteinases and snake venom haemorrhagins, from which the
disintegrin domains evolved after mammals and reptiles diverged
[27], prompted us to investigate possible evolutionary pathways
giving rise to the large structural diversity within different groups
of the disintegrin family.
METHODS
Purification of dimeric disintegrins
Freeze-dried venoms from V.l. obtusa, V. berus, E. ocellatus and E.
multisquamatus, purchased from Latoxan Serpentarium (Rosans,
France) and V. ammodytes (Sigma), were dissolved in 0.1%
trifluoroacetic acid (TFA) at a concentration of approx. 30 mg/ml.
Insoluble material was discarded after centrifugation at 5000 rev./
min for 5 min and the clear supernatant was fractionated by
reverse-phase HPLC on a Vydac C-18 (250 mm × 10 mm)
column (Vydac, Hesperia, CA, U.S.A.), eluting at 2 ml/min with a
linear gradient of 0.1% TFA in water (solution A) and 0.1%
TFA in acetonitrile (solution B). Chromatographic conditions
were 0–80% B over 45 min. Separations were monitored
at 220 nm, and fractions were collected manually and dried
using a Speed-Vac system. HPLC-separated fractions were
dissolved in water and tested for their ability to inhibit the
adhesion of cultured cells (see below). Active HPLC fractions
were rechromatographed using the same HPLC system but the
column was developed with a flatter gradient (0–60% B over
45 min). HPLC peaks displaying cell adhesion inhibition activity
were freeze-dried. Protein purity was tested by SDS/PAGE and
matrix-assisted laser-desorption ionization–time-of-flight mass
spectrometry (MALDI–TOF-MS), performed at the Wistar Mass
Spectrometry Facility (Philadelphia, PA, U.S.A.) and the Instituto
de Biomedicina de Valencia (Spain), using in both cases a
PE-Biosystems Voyager-DE Pro instrument and 3,5-dimethoxy-
4-hydroxycinnamic acid (sinapinic acid) saturated in 50%
acetonitrile and 0.1% TFA as matrix. For quantification of free
thiol groups and disulphide bonds, dimeric disintegrins [0.5 mg/
ml in 100 mM ammonium bicarbonate (pH 8.3), containing
6 M guanidinium chloride] were incubated either with 10 mM
iodoacetamide for 2 h at room temperature (24 ◦C) or with 1%
(v/v) 2-mercaptoethanol for 2 min at 100 ◦C, followed by the
addition of a 10-fold molar excess of 4-vinylpyridine over a
reducing agent and incubation for 1 h at room temperature.
Samples were dialysed against deionized (MilliQ) water, freeze-
dried, and were subjected to amino acid analysis (after sample
hydrolysis with 6 M HCl for 24 h at 110 ◦C) using a Pharmacia
AlphaPlus analyser, and MALDI–TOF-MS.
Cell adhesion inhibition assays
The following cell lines were employed: K562 cells transfected
with the α1, α2 and α6 subunits of integrins were provided by
Dr M. Hemler (Dana Farber Cancer Institute, Boston, MA,
U.S.A.); A5 cells and Chinese-hamster ovary (CHO) cells trans-
fected with the αIIbβ3 integrin were provided by Dr M Ginsberg
(Scripps Research Institute, La Jolla, CA, U.S.A.); K562 and
Jurkat cells, which express integrins α5β1 and α4β1 respectively,
were purchased from A.T.C.C. (Manassas, VA, U.S.A.). The
inhibition of cells labelled with 5-chloromethyl fluorescein
diacetate to ligands immobilized on a 96-well microtitre plate
(Falcon, Pittsburg, PA, U.S.A.) was assayed as described
previously [24]. Briefly, fibrinogen (provided by Dr A. Budzynski,
Temple University, Philadelphia, PA, U.S.A.), fibronectin
(Sigma), vitronectin (Chemicon, Ternecula, CA, U.S.A.), laminin
(ICN Biomedicals, Irvine, CA, U.S.A.), VCAM-1 (provided by
Dr P. Wainreb, Biogen Inc., Cambridge, MA, U.S.A.), collagen
types I and IV (Chemicon) were immobilized on a 96-well
microtitre plate (Falcon) in PBS (or in 0.02 M acetic acid for
collagens) overnight at 4 ◦C. Wells were blocked with 1% BSA
in Hanks balanced salt solution (HBSS) containing 3 mM CaCl2
and 3 mM MgCl2. The cells were labelled with fluorescein by
incubation at 37 ◦C for 15 min with 12.5 µM 5-chloromethyl
fluorescein diacetate in HBSS containing calcium and magnesium
(for collagen receptors, HBSS buffer containing 3 mM MgCl2).
Cells were freed from unbound ligand by washing with the same
buffer. Labelled cells (1 × 105/sample) were added to the wells in
the presence or absence of inhibitors and incubated at 37 ◦C for
30 min. Unbound cells were removed by aspiration, the wells
were washed and bound cells were lysed by adding 0.5% Triton
X-100. In parallel, the standard curve was prepared in the same
plate using known concentrations of labelled cells. The plates
were read using a Cytofluor 2350 fluorescence plate reader
(Millipore, Bedford, MA, U.S.A.) at an excitation wavelength
of 485 nm using a 530 nm emission filter.
Isolation and structural characterization
of pyridylethylated (PE) subunits
Dimeric disintegrins [0.5 mg/ml in 0.1 M Tris/HCl (pH 8.5), 4
mM EDTA, 6 M guanidinium chloride] were reduced with 3.2
mM dithiothreitol for 2 h at room temperature and in the dark.
Reduced proteins were alkylated by the addition of a 2-fold
molar excess of 4-vinylpyridine over a reducing reagent. PE
subunits were isolated by reverse-phase HPLC on a C18 column
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developed with a linear gradient of solution A and solution B,
and were denoted ‘A’ or ‘B’ according to their elution
order. The isolated PE subunits were initially characterized by
N-terminal sequencing (using either an Applied Biosystems
477A or a Beckman Porton LF-3000 instrument following the
manufacturer’s instructions), amino acid analysis and MALDI–
TOF-MS [as above but using α-cyano-4-hydroxycinnamic acid
saturated in 50% (v/v) acetonitrile and 0.1% TFA as the
matrix]. The primary structures of PE polypeptides were
deduced from N-terminal sequence analysis of overlapping
peptides obtained by proteolytic digestions with endoproteinases
Lys-C [2 mg/ml protein in 100 mM ammonium bicarbonate
(pH 8.3); Boehringer Mannheim] for 18 h at 37 ◦C using an
enzyme/substrate ratio of 1:100 (w/w) and degradation with
CNBr [10 mg/ml protein and 100 mg/ml CNBr in 70%
(v/v) formic acid for 6 h at room temperature, under N2
atmosphere and in the dark]. Peptides were separated by reverse-
phase HPLC using a 4 mm × 250 mm C18 (particle size = 5 µm)
Lichrospher RP100 (Merck) column eluting at 1 ml/min with a
linear gradient of solution A and solution B.
Disintegrin domain sequences
A non-redundant database of amino acid sequences of snake
venom disintegrins was constructed from primary literature
on disintegrins and by sequence homology searches in the
SwissProt, TREMBL (http://www.expasy.ch) and GenBank R©
(http://www.ncbi.nlm.nih.gov) databases using the BLAST pro-
gram [28] implemented in the WU-BLAST2 search engine at
http://www.bork.embl-heidelberg.de. Sequence alignment was
made by CLUSTALW program [29]. Databank accession
numbers or primary references for all sequences are given in
Figure 3. A list of the 233 disintegrin domain proteins from any
organism is available in the PFAM protein families’ database
addressing http://www.sanger.ac.uk/cgi-bin/Pfam/getallproteins.
pl?name=disintegrin&acc=PF00200&verbose=true&type=full&
zoom factor=0.5&list=View+Graphic and in the SMART
website (http://smart.embl-heidelberg.de/smart/get members.pl?
WHAT=NRDB COUNT&NAME=DISIN). The amino acid se-
quences of mammalian ADAM (a disintegrin and metal-
loproteinase-like) proteins were retrieved from http://www.
gene.ucl.ac.uk/nomenclature/genefamily/metallo.html.
Phylogenetic analysis
The package of programs PHYLIP (the PHYLogeny Inference
Package; obtained at: http://evolution.genetics.washington.edu/
Table 1 Comparison of the inhibitory activities of dimeric disintegrins on the adhesion of different cell lines expressing defined integrins to immobilized
ligands
The data represent the means for three experiments. Coll, collagen; LM, laminin; FN, fibronectin; FG, fibrinogen; α1-, α2- and α6-K562, K562 cells transfected with α1, α2 or α6 integrin subunits
respectively; A5, CHO cells transfected with αIIbβ3 integrin.
IC50 (nM)
Cell line Integrin receptor Ligand VB7 VLO5 EO5 EMS11 EO4 VLO4 VA6
α1-K562 α1β1 Coll IV > 10 000 > 10 000 > 10 000 > 10 000 > 10 000 > 10 000 > 10 000
α2-K562 α2β1 Coll I > 10 000 > 10 000 > 10 000 > 10 000 > 10 000 > 10 000 > 10 000
α6-K562 α6β1 LM > 10 000 > 10 000 > 10 000 > 10 000 > 10 000 > 10 000 > 10 000
K562 α5β1 FN 1.1 3400 690 6.0 1.2 3.5 3.8
Jurkat α4β1 VCAM-1 4830 5.5 9.5 14 1850 1400 2450
A5 αIIbβ3 FG 420 760 980 350 118 115 144
phylip.html) [30] and MEGA (Molecular Evolutionary Genetic
Analysis; http://www.megasoftware.net) [31] were employed
for inferring phylogenies (evolutionary trees) from a multiple
alignment of disintegrin sequences. Methods that are available in
the package include parsimony, distance matrix and likelihood
methods, including bootstrapping and consensus trees.
RESULTS AND DISCUSSION
Characterization of novel dimeric disintegrins
The venom proteins of E. ocellatus, E. multisquamatus, V.l.
obtusa, V. berus and V. ammodytes were separated by reverse-
phase HPLC. The fractions were denoted by the initials of
the snake species followed by the HPLC fraction number.
Screening against a panel of integrins [24] identified seven
proteins that were classified into three groups according to their
main integrin-inhibition specificity (Table 1). The first group
included disintegrins from the venoms of E. ocellatus (EO4), V.l.
obtusa (VLO4), V. berus (VB7) and V. ammodytes (VA6). These
disintegrins inhibited the adhesion of cells expressing the RGD-
dependent integrin α5β1 (K562) to immobilized fibronectin. The
second group comprising EO5 and VLO5 blocked the adhesion
of the α4β1 integrin to VCAM-1. The third group included
disintegrin from the venom of E. multisquamatus (EMS11),
which inhibited the adhesion of both K562 and Jurkat cells to
immobilized fibronectin and VCAM-1 respectively, with almost
the same degree of specificity. The inhibitory activity of these
seven disintegrins on the adhesion of A5 cells (CHO cells
transfected with integrin αIIbβ3) to fibrinogen was 50–100-fold
lower than their main integrin-inhibitory activity. On the other
hand, none of the disintegrins significantly inhibited the binding
of K562 cells expressing integrins α1β1, α2β1 and α6β1 to their
respective immobilized ligands (Table 1).
The seven proteins were purified to homogeneity using
the two-step reverse-phase HPLC method used in previous
studies [6,7,26,32]. Figure 1 illustrates the steps along the
purification protocol of native disintegrin VB7 and its PE
subunits. The other disintegrins and their subunits were purified
according to the same general scheme. SDS/PAGE showed that
each of these proteins had apparent molecular masses of 14–
15 kDa (non-reducing conditions) and 7 kDa (reduced samples),
indicating that each of the seven proteins contained two
disulphide-bonded subunits. Reverse-phase HPLC was used to
separate the subunits after reduction and pyridylethylation of
the native proteins, and the purified subunits were denoted
PE-‘A’ or PE-‘B’ according to their elution order. Table 2
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Figure 1 Purification of dimeric disintegrins
The procedure followed in the purification of disintegrin VB7 is illustrated.(A) Reverse-phase chromatographic separation (0–80 % B over 45 min) of the crude venom of V. berus. The elution position
of purified VB7 is indicated by an asterisk. (B) Fraction VB7 from (A) was further purified using the same HPLC system as in (A) but developing the column with a flatter gradient (0–60 % B over
45 min). The inset shows a MALDI–TOF-MS analysis of purified VB7. (C) Reverse-phase HPLC separation of the PE subunits of VB7. The mass spectra of PE-VB7A and PE-VB7B are shown. (D)
SDS/PAGE of non-reduced (lane a) and reduced (lane b) VB7, purified as in (B). Lanes d and e, PE-A and PE-B subunits of VB7 isolated as in (C). Lane c, molecular-mass markers (Bio-Rad, Hercules,
CA, U.S.A.), from top to bottom: phosphorylase b (103 kDa), BSA (77 kDa), ovalbumin (50 kDa), carbonic anhydrase (34 kDa), soya-bean trypsin inhibitor (23 kDa) and lysozyme (14 kDa).
Table 2 Molecular features of native disintegrins and their subunits
isolated from the venoms of E. ocellatus (EO), E. multisquamatus (EMS),
V.l. obtusa (VLO), V. berus (VB) and V. ammodytes (VA)
Molecular mass (kDa)
PE subunits Integrin-binding motif
Disintegrin Native A B A B
EO4 14.526 8.416 8.196 RGD VGD
EO5 14.515 8.456 8.196 MLD VGD
EMS11 14.908 8.521 8.514 MLD n.d.*
VLO4 14.196 8.163 8.163 RGD RGD
VLO5 14.728 8.165 8.690 VGD MLD
VB7 13.969 8.062 8.034 RGD KGD
VA6 14.046 8.078 8.078 RGD RGD
*n.d., not determined.
shows the molecular masses of the native proteins and their PE
subunits from MALDI–TOF-MS. The molecular masses of the
native proteins did not change on incubation with alkylating
reagents in denaturing, non-reducing buffers, showing that EO4,
EO5, EMS11, VLO4, VLO5, VB7 and VA6 did not contain
free thiol groups. On the other hand, the mass difference of
approx. 2.128 kDa between the sum of the PE subunits and
the native proteins indicated that each disintegrin contained 20
cysteine residues involved in the formation of ten inter- and
intrasubunit disulphide bonds. The amino acid sequences of
EO4, EO5, EMS11, VLO4, VLO5, VB7 and VA6 subunits were
established using automated Edman degradation of the reduced
and PE protein and of peptides obtained after degradation of the
PE subunits with endoproteinase Lys-C and CNBr (Figure 2).
The polypeptides display a large amino acid sequence similarity
between themselves and with the members of the subfamily of
dimeric disintegrins (Figure 3), including the position of ten
cysteine residues per subunit, which is a conserved feature of
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Figure 2 Amino acid sequences (one-letter code) of disintegrin subunits
isolated from the venoms of E. ocellatus (EO), V.l. obtusa (VLO), V. berus
(VB) and V. ammodytes (VA)
The sequences were established by automated Edman degradation of the PE proteins and of
overlapping peptides isolated by reverse-phase HPLC after degradation of the PE proteins with
endoproteinase Lys-C (K) and CNBr. VLO4 and VA6 are homodimers.
all polypeptides of this group. Except for VLO4 and VA6, which
are homodimers, all the other proteins are heterodimers. EO4 and
EO5, the two dimeric disintegrins isolated from the venom of
E. ocellatus, share the B subunit (Table 2, Figure 2). Similarly,
EC3 and EC6, two dimeric disintegrins from the venom of E.
carinatus ( = E.c. sochureki or E. sochureki) [6,32], and CC5 and
CC8, from Cerastes cerastes venom [26], also have a common
subunit. Hence, sharing of subunits may represent an effective
mechanism of structural and functional diversification of dimeric
disintegrins.
It is worth noting that those disintegrins that block the function
of α5β1 integrin (EO4, VLO4, VB7 and VA6) contain RGD or
KGD in both subunits, with the exception of EO4, which possesses
a VGD sequence in its B subunit, and EMS11, which expresses
an MLD motif in its A subunit (Figure 2, Table 2). The RGD
motif is expressed at the apex of the integrin-binding loop of
most monomeric disintegrins (Figure 3) and is responsible for the
inhibitory activity of these disintegrins towards integrins that bind
to ligands through RGD sites, including the fibronectin receptor,
namely the α5β1 integrin. Furthermore, the VGD sequence
present in EC3A and also its related sequence MGD, found in
EMF-10B, have been shown to contribute to the inhibitory activity
of these disintegrins towards the α5β1 integrin [6,7]. On the other
hand, our results on α4β1-inhibitory activities of EO5, EMS11
and VLO5 (Table 1) agree with previous studies showing that the
specificity of EC3 for α4 integrins resides in the MLD sequence
of the B subunit [6].
The late discovery of dimeric disintegrins is because these
are poor inhibitors of platelet aggregation, and monomeric
disintegrins were first described as potent inhibitors of the
platelet fibrinogen receptor, integrin αIIbβ3 [4,33]. The isolation
and characterization of disintegrins, which do not inhibit platelet
aggregation (i.e. non-RGD-containing dimeric disintegrins),
was achieved with the development, in the late 1990s, of cell
adhesion inhibition assays using cell lines transfected with
defined integrins [6,7,24]. Our results indicate that dimeric
disintegrins are widely distributed in Echis and Vipera venoms,
and probably also in the venoms of many other species of
Crotalidae and Viperidae, which are rich sources of monomeric
disintegrins. It is worth mentioning that non-RGD disintegrins
are present in venoms which also contain RGD disintegrins [i.e.
E. ocellatus: ocellatusin (RGD), EO4B (VGD), EO5 (MLD
and VGD); E. carinatus ( = E.c. sochureki or E. sochureki):
echistatin (RGD), EC3 (VGD and MLD), EC6A (MLD); V.l.
obtusa: VLO4 (RGD), obtustatin (KTS), VLO5 (VGD and
MLD); Eristocophis macmahoni: eristostatin (RGD), EMF-10B
(MGD)]. The large sequence and structural diversity exhibited
by the different subfamilies of disintegrins (Figure 2) strongly
suggests that disintegrins, like toxins from other venoms [34,35],
have evolved rapidly by adaptative evolution driven by positive
Darwinian selection. The co-existence in the same snake species
of disintegrins with conserved RGD motif and disintegrins
with variable non-RGD sequences supports the hypothesis [36]
that, following gene duplication, one copy of the gene (i.e. the
one coding for an RGD disintegrin) will divergently evolve
under pressure dictated by the ancestral function (blocking of
platelet aggregation), whereas the duplicate gene(s) (non-RGD
disintegrin), unencumbered by a functional role, is (are) free to
search for new physiological roles such as inhibition of non-RGD-
dependent integrin receptors. As judged from the consensus se-
quences of the different disintegrin subfamilies shown in Figure 3,
the integrin-binding loop represents a mutational ‘hot spot’
and the only conserved characteristic (except in obtustatin) is the
presence of an acidic residue [D in short (dimeric)-, medium-
and long-sized disintegrins; E or D in disintegrin/cysteine-rich
domains] at the C-terminal site of the integrin-binding motif.
The crystal structure of the extracellular segment of integrin
αvβ3 in complex with an RGD ligand [37] shows that the
peptide fits into a crevice between the αV propeller and the β3
A-domain. The arginine side chain is held in place by interactions
with αV carboxylates 218 and 150, the glycine residue makes
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Figure 3 Figure legend see facing page
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several hydrophobic interactions with αV and the aspartate ligand
interacts primarily with βA residues. Thus, in agreement with
our results, the conserved aspartate residue might be responsible
for the binding of disintegrins to integrin receptors which share
a β-subunit, whereas the other two residues of the integrin-
binding motif (RG, MG, WG, ML, VG) may dictate the integrin
specificity.
Phylogenetic analysis: structural diversification of disintegrins by
disulphide bond engineering
Figure 4 displays a dendrogram for the multiple-sequence
analysis of disintegrin domains listed in Figure 3, and it also
includes the disintegrin domain of ADAMs from which snake
venom disintegrins evolved after mammals and reptiles diverged
[27]. The most prominent characteristic of this tree is that
the members of the different subfamilies are almost perfectly
clustered separately with their homologues, suggesting a possible
evolutionary relationship between the different disintegrin
subfamilies (Figure 5A). Proteins composed of disintegrin and
cysteine-rich domains, derived from PIII snake venom
metalloproteinases, are the closest homologues of cellular
ADAMs. Comparison of full-length cDNA sequences of ADAMs
and PIII SVMPs shows that the genes coding for the latter
molecules possess 3′-untranslated regions, which include STOP
codons after the cysteine-rich domain. Thus PIII SVMPs are
not simply derived by proteolysis of ADAM molecules, but
have rather evolved from a common ancestor after having lost
the genetic information coding for protein regions downstream
of the cysteine-rich domain (epidermal growth factor-like,
transmembrane and cytoplasmic domains). Further deletions
of gene regions coding for (i) the C-terminal portion of the
disintegrin domain (including Cys-16) and the cysteine-rich
domain and (ii) Cys-13, which is disulphide-bonded to Cys-16,
gave rise to long-sized disintegrins (Figure 5A). Disintegrins are
small in size and possess a high density of disulphide bonds.
A close examination of the conserved cysteine residues in each
disintegrin subfamily (Figure 3) strongly indicates that the struc-
tural diversity of disintegrins has been achieved during evolution
through the selective loss of disulphide bonds (Figure 5A).
Hence, mutations in the codon of Cys-1, along with a deletion of
nine bases coding for the tripeptide CQ(D/N) from a long-sized
disintegrin ancestor, resulted in the removal of the disulphide bond
between Cys-1 and Cys-4 and the emergence of medium-sized
disintegrins (Figure 5B). Further mutations involving the codons
of the first two cysteine residues of medium-sized disintegrins
(Cys-2 and Cys-3 in Figure 5B) yielded polypeptides with ten
cysteine residues. The disulphide bond pattern of these disintegrin
chains follows the same scheme as that of medium-sized dis-
integrins (Figure 5), except that the two cysteine residues (Cys-6
and Cys-7; Figure 5), which in medium-sized disintegrins are
disulphide-bonded to Cys-3 and Cys-2 respectively, are engaged
in two interchain disulphide bonds with homologous cysteine
residues from another 10-cysteine-residue-containing disintegrin
[17], giving rise to homo- and heterodimers [5–7,26,32,38,39].
The fact that the amino acid sequences of the subunits of the
Figure 3 Multiple amino-acid sequence analysis of disintegrins
The one-letter code for amino acid nomenclature is used. Cysteine residues are shadowed in pale grey. Non-RGD integrin-binding tripeptide motifs are underlined and shown in bold. Amino acid
characteristics which define the signature of each disintegrin subfamily are shown in the ‘Consensus’ line using the following code: a, aromatic (F, Y, W); h, hydrophobic (L, I, V, M, A); t, turn-like
or polar (G, P, N, Q, H, S, T); −, negatively charged (E, D); +, positively charged (K, R); *, charged (E, D, K, R); p, conservative (N, D, Q, E); 2, one of the two residues in any sequence. Where
available, databank accession numbers are given. TW, this work (present study). The amino acid sequences of the following disintegrins were extracted from primary references: ocellatusin [45],
multisquamatin [46], pyramidin A [46], leucogastin B [46], piscivostatin 2A and 2B [47], ussuristatin [20], bilitoxin-1 [18], saxatilin [48] and graminelysin [49].
Figure 4 Dendrogram for the multiple-sequence analysis of disintegrin
domains listed in Figure 3
The tree represents the minimum evolutionary distance estimated through neighbour joining
using maximum likelihood distances. Maximum parsimony produced a similar topology.
Representative disintegrin domains of human (hu), mouse (mm), guinea-pig (gp) and Xenopus
(xl) ADAMs are also displayed. The length of the horizontal scale bar represents 10 % divergence.
Phylogenetic distances at branch points are indicated.
dimeric disintegrins piscivostatin and contortrostatin cluster with
the medium-sized disintegrins (Figure 4) further suggests that
these dimeric disintegrins may have evolved from a medium-
sized disintegrin ancestor. Finally, and although cDNA sequences
c© 2003 Biochemical Society
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Figure 5 Proposed evolutionary relationship between the different disintegrin subfamilies
(A) Scheme of the domain organization and disulphide bond patterns of proteins from the different disintegrin subfamilies. A precursor ADAM molecule is shown at the top. Cysteine residues are
numbered from 1 to 16. Disulphide bonds, which are removed in the hypothetical evolutionary pathway from disintegrin/cysteine-rich proteins to short-sized disintegrins, are indicated by thick
lines, and possible evolutionary pathways in the evolution of the different disintegrin subfamilies are indicated by arrows. The disulphide bond Cys-1–4 absent from graminelysin, a member of
the disintegrin/cysteine-rich subfamily, is indicated by a broken line. A hypothetical pathway from a gramelysin-type disintegrin to a medium-sized disintegrin is indicated by an arrow over the
broken line. The cysteine residues engaged in the short-sized-disintegrin-specific disulphide bond are labelled. 3a indicates the position of an extra cysteine residue in bilitoxin-1. The position of
the integrin-binding motif is shown as a white cone. (B) Alignment of the nucleotide sequences of cDNAs coding for representative members of the disintegrin subfamilies, catrocollastatin-C [41]
(disintegrin/cysteine-rich), salmosin-3 [42] (long), trigramin [43] (medium-sized) and contortrostatin [44] (dimeric). Mutations and deletions affecting the cysteine residue content in the molecule
are in boldface. N-terminal sequences of the mature proteins are double underlined.
of short-sized disintegrins are not available, the formation of short-
sized disintegrins implies deletion or mutation of Cys-1–7 and the
appearance of another cysteine residue between Cys-15 and Cys-
16 (15a in Figure 5A), involved in the formation of a short-
sized-disintegrin-specific disulphide bond with Cys-8, and which
otherwise would remain unpaired. Clearly, genetic information is
eagerly awaited to ascertain whether short-sized disintegrins have
arisen from long/medium-sized or 10-cysteine-residue-containing
disintegrins.
Although the vast majority of the disintegrins listed in Figure 3
might follow the canonical scheme outlined above, the
evolutionary scenario of the disintegrin family might be more
complex. Thus graminelysin departs from this pathway. It contains
the Cys-13–16 disulphide bond specific to disintegrin/cysteine-
rich domains, but clusters with the medium-sized disintegrins,
and similar to them has serine in the place of Cys-1 and lacks
the CQ(D/N) region. Hence, graminelysin might represent an
intermediate step in an alternative route in the evolution
of medium-sized disintegrins from disintegrin/cysteine-rich
proteins. Bilitoxin-1, a long-sized disintegrin from Agkistrodon
bilineatus venom [18], possesses an extra cysteine residue
between Cys-3 and Cys-4 (Figure 3; also marked with an
arrow in Figure 5A) involved in the formation of a disulphide-
bonded homodimer. MD2, from Agkistrodon acutus, represents
another unique disintegrin. It is closely related to medium-sized
disintegrins, but lacks four cysteine residues (Cys-2, -3, -5 and
-10), and its disulphide-bond pattern and aggregation state remain
to be determined. Furthermore, proteins containing disintegrin
and cysteine-rich domains have also been identified in the
venoms of snakes belonging to the families Atractaspidae (mole
vipers) and Elapidae (cobras, kraits, coral snakes) (kaouthiagin
[40], atractaspin, mocarhagin, Q9PT47 and Q9PT48; Figure 3).
Strikingly, two of these proteins, namely kaouthiagin from Naja
kaouthia venom and Q9PT48 from Atractaspis engaddensis
venom, have a large deletion including Cys-8, -9, -10 and -11
(Figure 3). Kaouthiagin expresses the HDCD motif in its
disintegrin domain and an RGD sequence in its cysteine-rich
domain, and has inhibitory activity on collagen-induced platelet
aggregation with IC50 of 0.2 µM. Studies with synthetic peptides
based on the HDCD and RGD motifs indicated that both
sequences may act synergistically to block collagen-induced
platelet aggregation [40]. On the other hand, the occurrence of
disintegrins in venoms of neurotoxic snakes indicates that the
distribution of disintegrins is not restricted to the haemorrhagic
venoms of Crotalidae and Viperidae snakes.
The specificity of disintegrins is due to their disulphide-
bonding framework and specific amino acids in intercysteine
loops. The high content of disulphides plays a vital role in
their stability and imposes a distinct protein folding, with a
specific orientation of the loop regions. Our results support the
view that the different disintegrin subfamilies have evolved from
a common ADAM scaffold and that structural diversification
occurred through disulphide bond engineering.
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